Shionogi said previously it expected the pill, known commercially as Xocova, to deliver $2 billion in annual sales if it secured U.S. approval.
Tag Archive for: Japan
The company expects to reach 90% of its target for integrated delivery networks (IDNs) used to administer the drug in the U.S. in the fiscal year ending this month, its CEO stated.
The Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biological E.
Viz.ai continues to demonstrate significant real-world evidence on the patient and economic outcomes of AI-powered care coordination; Neurolief’s neuromodulation device Relivion is approved by the Japanese Ministry of Health, Labor and Welfare; and Kanerika partners with Microsoft to build an enterprise business intelligence platform powered by Microsoft Fabric for a leading global pharmaceutical company in the United States.
Alvotech said on Thursday it has reached settlement agreements with Johnson & Johnson for launching a biosimilar of the pharmaceutical giant’s blockbuster psoriasis drug Stelara in Japan, Canada, and Europe this year.
Biogen has disclosed in a Wednesday Securities and Exchange Commission filing that it has been served a subpoena by the U.S. Department of Justice, which is seeking more information regarding the company’s overseas operations.
Intravenous treatment of the drug, co-developed with U.S. partner Biogen (BIIB.O), will cost about 2.98 million yen ($20,438) per patient per year.
The mRNA-based shot was initially approved as a booster in August, becoming Japan’s first home-grown shot for the coronavirus.
Today the company reported higher-than-expected results in the third quarter on surprisingly strong demand for its COVID-19 treatment, primarily in Japan, and raised its annual sales forecast for the therapy.
The development comes after a health ministry panel recommended the drug’s approval in August, followed by standard approval from the U.S. Food and Drug Administration (FDA) in July.